Half Yearly, page-13

Hey Astral do us a favour, give Stephen Carter a ring (he is back according to Marg) and ask him to update you on the following (oh and report back to us what he says):

1. Zolpimist first milestone payments,
2. Zolpimist first royalty timelines
3. Zolpi marketing application lodgement updates,
4. Artimist key timeline update TGA and sale,
5. What's happened to Zolpi Euro and 002 deals
6. Pfizer update when does the option expire and what next ...?
7. Anagrelide timelines
8. Our priority project midazolam.... Not a word on it since it became a "priority"
9. Any kind of update on 001 and strides and give some timelines,
10.Address the development costs associated with the Strides deal
11. Update on Co development deals in the pipeline and special attention to Cannabanoid.
12. 001 Euro deal update 
13. CY guidance

OH AND IF HE AND HIS COMPADRES ARE GOING TO BUY ANY SUDA SHARES

That would be lovely - thanks